Literature DB >> 9546786

TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation.

M Sata1, K Walsh.   

Abstract

It is generally believed that the vascular endothelium serves as an inflammatory barrier by providing a nonadherent surface to leukocytes. Here, we report that Fas ligand (FasL) is expressed on vascular endothelial cells (ECs) and that it may function to actively inhibit leukocyte extravasation. TNFalpha downregulates FasL expression with an accompanying decrease in EC cytotoxicity toward co-cultured Fas-bearing cells. Local administration of TNFalpha to arteries downregulates endothelial FasL expression and induces mononuclear cell infiltration. Constitutive FasL expression markedly attenuates TNFalpha-induced cell infiltration and adherent mononuclear cells undergo apoptosis under these conditions. These findings suggest that endothelial FasL expression can negatively regulate leukocyte extravasation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546786      PMCID: PMC2828686          DOI: 10.1038/nm0498-415

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  37 in total

1.  Immune response and myoblasts that express Fas ligand.

Authors:  S M Kang; A Hoffmann; D Le; M L Springer; P G Stock; H M Blau
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

2.  Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response.

Authors:  A C van der Wal; P K Das; D Bentz van de Berg; C M van der Loos; A E Becker
Journal:  Lab Invest       Date:  1989-08       Impact factor: 5.662

3.  Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after Systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts.

Authors:  D A Muruve; A G Nicolson; R C Manfro; T B Strom; V P Sukhatme; T A Libermann
Journal:  Hum Gene Ther       Date:  1997-05-20       Impact factor: 5.695

4.  Cardiac transplant atherosclerosis.

Authors:  M E Billingham
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

5.  Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response.

Authors:  M Sata; H Perlman; D A Muruve; M Silver; M Ikebe; T A Libermann; P Oettgen; K Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

6.  An immunohistochemical analysis of human aortic fatty streaks.

Authors:  J M Munro; J D van der Walt; C S Munro; J A Chalmers; E L Cox
Journal:  Hum Pathol       Date:  1987-04       Impact factor: 3.466

7.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

9.  T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis.

Authors:  E E Emeson; A L Robertson
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

10.  Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.

Authors:  X N Xu; G R Screaton; F M Gotch; T Dong; R Tan; N Almond; B Walker; R Stebbings; K Kent; S Nagata; J E Stott; A J McMichael
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  40 in total

1.  Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria.

Authors:  P Kern; M Dietrich; C Hemmer; N Wellinghausen
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Intravenous immunoglobulin (IVIG) preparations induce apoptosis in TNF-alpha-stimulated endothelial cells via a mitochondria-dependent pathway.

Authors:  K Nakatani; S Takeshita; H Tsujimoto; I Sekine
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

Review 3.  Gene therapy for restenosis.

Authors:  R C Smith; K Walsh
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

4.  Endothelial Fas-Ligand in Inflammatory Bowel Diseases and in Acute Appendicitis.

Authors:  Tuomo S Kokkonen; Tuomo J Karttunen
Journal:  J Histochem Cytochem       Date:  2015-09-15       Impact factor: 2.479

5.  Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation.

Authors:  Toshimitsu Suhara; Hyo-Soo Kim; Lorrie A Kirshenbaum; Kenneth Walsh
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

6.  Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium.

Authors:  Mehmet H Kural; Juan Wang; Liqiong Gui; Yifan Yuan; Guangxin Li; Katherine L Leiby; Elias Quijano; George Tellides; W Mark Saltzman; Laura E Niklason
Journal:  Biomaterials       Date:  2019-05-07       Impact factor: 12.479

7.  The parallel lives of angiogenesis and immunosuppression: cancer and other tales.

Authors:  Gregory T Motz; George Coukos
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

8.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  The Relationship of Serum Soluble Fas Ligand (sFasL) Level with the Extent of Coronary Artery Disease.

Authors:  Asife Sahinarslan; Bulent Boyaci; Sinan Altan Kocaman; Salih Topal; Ugur Ercin; Kaan Okyay; Neslihan Bukan; Ridvan Yalçin; Atiye Cengel
Journal:  Int J Angiol       Date:  2012-03

10.  TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.

Authors:  Haishan Li; Kun Luo; C David Pauza
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.